Bamco Inc. NY decreased its position in shares of Afya Limited (NASDAQ:AFYA – Free Report) by 9.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 2,966,658 shares of the company’s stock after selling 310,623 shares during the quarter. Bamco Inc. NY owned approximately 3.17% of Afya worth $55,121,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in AFYA. Renaissance Group LLC raised its holdings in shares of Afya by 6.1% in the 4th quarter. Renaissance Group LLC now owns 149,137 shares of the company’s stock valued at $3,271,000 after acquiring an additional 8,524 shares in the last quarter. Doma Perpetual Capital Management LLC purchased a new stake in Afya in the fourth quarter valued at approximately $6,467,000. Dodge & Cox raised its stake in Afya by 7.0% in the fourth quarter. Dodge & Cox now owns 29,183 shares of the company’s stock valued at $640,000 after purchasing an additional 1,900 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in Afya in the fourth quarter valued at approximately $245,000. Finally, HBK Sorce Advisory LLC raised its stake in Afya by 10.0% in the fourth quarter. HBK Sorce Advisory LLC now owns 11,044 shares of the company’s stock valued at $242,000 after purchasing an additional 1,000 shares in the last quarter. Institutional investors own 88.02% of the company’s stock.
Afya Price Performance
Shares of AFYA stock traded up $0.33 during trading hours on Friday, hitting $18.05. 125,630 shares of the company’s stock were exchanged, compared to its average volume of 126,737. The company has a market capitalization of $1.69 billion, a PE ratio of 16.87, a PEG ratio of 0.47 and a beta of 0.97. Afya Limited has a 12-month low of $14.27 and a 12-month high of $22.48. The business’s 50 day simple moving average is $17.36 and its 200-day simple moving average is $18.67. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 0.42.
Wall Street Analysts Forecast Growth
Separately, Morgan Stanley lowered their target price on shares of Afya from $21.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, June 21st.
Get Our Latest Analysis on AFYA
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Read More
- Five stocks we like better than Afya
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is Crypto Cool Again? What Stocks You Should Be Watching
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Call Options Volume for These 2 Stocks Spiked Together
- Transportation Stocks Investing
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.